Tumors or cancer of the CONJUNCTIVA.
Tumors or cancer of the PANCREAS. Depending on the types of ISLET CELLS present in the tumors, various hormones can be secreted: GLUCAGON from PANCREATIC ALPHA CELLS; INSULIN from PANCREATIC BETA CELLS; and SOMATOSTATIN from the SOMATOSTATIN-SECRETING CELLS. Most are malignant except the insulin-producing tumors (INSULINOMA).
New abnormal growth of tissue. Malignant neoplasms show a greater degree of anaplasia and have the properties of invasion and metastasis, compared to benign neoplasms.
Neoplasms containing cyst-like formations or producing mucin or serum.
Tumors or cancer of the SKIN.
Two or more abnormal growths of tissue occurring simultaneously and presumed to be of separate origin. The neoplasms may be histologically the same or different, and may be found in the same or different sites.
Tumors or cancers of the KIDNEY.
Abnormal growths of tissue that follow a previous neoplasm but are not metastases of the latter. The second neoplasm may have the same or different histological type and can occur in the same or different organs as the previous neoplasm but in all cases arises from an independent oncogenic event. The development of the second neoplasm may or may not be related to the treatment for the previous neoplasm since genetic risk or predisposing factors may actually be the cause.
An adenocarcinoma producing mucin in significant amounts. (From Dorland, 27th ed)
Tumors or cancer of the THYROID GLAND.
Conditions which cause proliferation of hemopoietically active tissue or of tissue which has embryonic hemopoietic potential. They all involve dysregulation of multipotent MYELOID PROGENITOR CELLS, most often caused by a mutation in the JAK2 PROTEIN TYROSINE KINASE.

Immunoglobulin VH gene expression among extranodal marginal zone B-cell lymphomas of the ocular adnexa. (1/169)

PURPOSE: Most lymphomas of the ocular adnexa are primary extranodal non-Hodgkin's lymphomas of the B-cell type, with the most common lymphoma subtype being the extranodal marginal-zone B-cell lymphoma (EMZL). Analysis of somatic mutations in the variable (V) region of the Ig heavy (H)-chain gene segment suggests that EMZL development in other locations is dependent on antigen stimulation. The purpose of this study was to analyze the presence of somatic hypermutations in clonally rearranged Ig H-chain V genes of this lymphoma entity in the ocular adnexa and to estimate whether the mutation pattern is compatible with antigen selection. METHODS: Twenty-six cases of EMZL of the ocular adnexa were diagnosed on the basis of morphology, histology, and immunohistology. A nested polymerase chain reaction (PCR) was performed on DNA extracted from paraffin sections. The isolated PCR products were sequenced and compared with published VH germline segments to determine the number of somatic mutations in the complementarity-determining region (CDR) 2 and framework (FW) region 3. RESULTS: The number of somatic mutations in the cases of EMZL varied between 0 and 24: Five cases involved 0 to 3 somatic mutations, and the remaining 21 cases involved 4 to 24 mutations. Based on the ratio of replacement (R) to silent (S) mutations in the CDR2 or FW3 regions, antigen selection seems to have occurred in 60% of ocular adnexal EMZL. The VH3 family was the most commonly expressed germline VH family (54%), followed by VH4 (23%), with biased usage of the latter. Some germline VH1 genes used included DP-8, DP-10, DP-53, DP-63 (VH4.21), and DP-49, which are frequently used by autoantibodies (e.g., rheumatoid factors) and natural autoantibodies. CONCLUSIONS: EMZLs of the ocular adnexa have an Ig H-chain mutation pattern that supports the concept that they represent a clonal expansion of post-germinal-center memory B-cells in most instances. In two thirds of cases, antigen selection may have occurred, and autoantibodies may have a role in their development.  (+info)

Intraepithelial and invasive squamous cell carcinoma of the conjunctiva: analysis of 60 cases. (2/169)

AIM: To evaluate the clinical features, treatment results, and recurrence rates in patients with either intraepithelial or invasive squamous cell carcinoma of the conjunctiva. METHODS: Retrospective analysis of 60 cases (22 conjunctival intraepithelial and 38 invasive squamous cell carcinomas) to determine patterns of clinical presentation, aetiological factors, and treatment results. The mean patient age was 64 years old. 70% of the patients were male. Patients were treated with a variety of therapies, depending on the degree of tumour involvement; most cases were treated with frozen section controlled excision and adjunctive cryotherapy. Modified eye wall resection or enucleation was done for intraocular invasion and exenteration was done for orbital involvement. RESULTS: Red eye (68%) and ocular irritation (57%) were the most common presenting symptoms. 44% of the patients had other eye findings consistent with extensive solar exposure. 20% of the patients had a history of malignant skin tumours. Visceral malignancies developed in 8%. Scleral involvement was present in 14 (37%), intraocular involvement in five (13%), and orbital invasion in four (11%) cases with invasive squamous cell carcinoma. After a mean follow up of 56 months (18-226 months) the rate of new or recurrent tumours was 4.5% for intraepithelial squamous carcinoma and 5.3% for invasive squamous cell carcinoma. No patient developed metastases or tumour related deaths. CONCLUSION: Excision with intraoperative control of the surgical margins and adjunctive cryotherapy results in good tumour control rates.  (+info)

Conjunctival squamous cell carcinoma in Tanzania. (3/169)

AIMS: To assess changes in incidence of conjunctival squamous cell carcinoma over a 22 year period in Tanzania and to analyse possible reasons for change. METHODS: Retrospective analysis of records from a Tanzanian pathology department serving north and central Tanzania from 1976 to 1997; medical record analysis of cases of conjunctival squamous cell carcinoma presenting in the last 2 years of the study. RESULTS: There was a sharp rise in the incidence of conjunctival squamous cell carcinoma in the last 3 years of the study (1995-7). The mean age of patients presenting with the condition over the full period was 44.7 years (95% confidence interval 42.4-46.9 years). In the final 2 years of the study the mean length of history on presentation was 3.1 months (2.1-4.0 months). Several patients had a previous history of chronic conjunctival disease such as allergic conjunctivitis and trachoma; one had had a conjunctival papilloma excised previously. Only five patients had been tested for HIV status, but of these four were positive. CONCLUSION: Tanzania is experiencing an epidemic of conjunctival squamous cell carcinoma similar to that seen in other African countries. Often the tumours are aggressive and occur in patients of relatively young age. The epidemic appears to be related to HIV infection, on a background of ultraviolet light exposure. Previous chronic conjunctival disease and exposure to human papillomavirus may also have a role.  (+info)

Conjunctival MALT lymphoma: an usual cause of red eye. (4/169)

We describe a patient presenting with a red eye who was found to have conjunctival non-Hodgkin's lymphoma of the mucosa-associated lymphoid tissue (MALT) type.  (+info)

Treatment of conjunctival squamous cell carcinoma with topical 5-fluorouracil. (5/169)

AIM: To evaluate the efficacy of topical 5-fluorouracil (5-FU) alone, without concurrent surgery or radiotherapy, for the treatment of conjunctival squamous cell carcinoma. METHODS: Eight patients affected by conjunctival squamous cell carcinoma (three recurrent cases, three incompletely excised, and two untreated cases) were treated with 1% 5-FU eye drops. Topical 1% 5-FU was administered four times daily for 4 weeks (one course). Clinical examination (biomicroscopy and photography) and morphological evaluation of conjunctival cytological specimens were used to monitor the efficacy of local chemotherapy, side effects, and recurrences. RESULTS: All patients showed clinical regression of conjunctival carcinoma after topical 1% 5-FU treatment. Neoplastic conjunctiva was completely replaced by normal epithelium within 3 months. Mean follow up was 27 months. One patient needed two courses of local chemotherapy for recurrent disease. An acute transient toxic keratoconjunctivitis was observed in all treated cases; it was easily controlled with topical therapy. No long term side effects were found. CONCLUSIONS: Topical 1% 5-FU is effective in the treatment of recurrent, incompletely excised, and selected untreated conjunctival squamous cell carcinomas. Topical 1% 5-FU has no major complications. This study suggests that topical conjunctival chemotherapy with 1% 5-FU may be useful, at least as adjunctive therapy, in the treatment of conjunctival squamous cell carcinoma.  (+info)

Indeterminate melanocytic proliferations of the conjunctiva. (6/169)

PURPOSE: The purpose of this study is to test the hypothesis that a subset of conjunctival melanocytic proliferations exists that cannot be reproducibly classified as benign, malignant, or indeterminate. METHODS: Three groups of excisional biopsy specimens of conjunctival melanocytic proliferations were evaluated by 5 ophthalmic pathologists. These groups included lesions that were considered by the authors to represent benign (Group 1, n = 5), malignant (Group 2, n = 5) and indeterminate melanocytic proliferations (Group 3, n = 5). The panel classified the same sections in all 3 groups in a randomized, masked fashion, first without and then with a clinical history of patient age, sex and race. The kappa statistic (k) was used to quantify the degree of agreement among observers. RESULTS: There was strong concordance among the panel for both Group 1 (benign, k = 0.76) and Group 2 (malignant, k = 0.70) melanocytic proliferations. There was no concordance of the panel for Group 3 (indeterminate) lesions (k = -0.045). The concordance for Groups 1 and 2 and lack of concordance for Group 3 lesions were independent of knowledge of clinical history of age, sex, and race. CONCLUSIONS: A subset of melanocytic proliferations of the conjunctiva exists that cannot be reproducibly classified by pathologists as benign, malignant, or indeterminate.  (+info)

Combined nevi of the conjunctiva. (7/169)

PURPOSE: To report the clinical and histologic features of combined nevi of the conjunctiva, a type of nevus that is not uncommon in the skin but has rarely been reported in the conjunctiva. METHODS: Conjunctival nevi and melanomas from the files of the University of California, San Francisco, eye pathology laboratory were reviewed from 1984 to 1999 for the presence of features of both standard nevocytic nevi and blue nevi. Clinical histories and, when available, clinical photographs were obtained. RESULTS: Thirty-one combined nevi were discovered during the 15-year period between 1984 and 1999. One case before 1984 had been incorrectly diagnosed as a junctional nevus. The dendritic and spindle-shaped blue nevus cells had been overlooked because they were not recognized as distinct from the standard nevocytic nevus cells. The recognition of a blue as well as a brown color, a deep as well as a superficial component in the lesion, or a history of pigmentation since birth may help to establish the correct clinical diagnosis and prevent an unnecessarily deep surgical resection. Although growth of the lesion or "satellites" in some patients may favor a clinical diagnosis of melanoma, none of the lesions in this series were malignant. CONCLUSION: Despite a paucity of reports of combined nevi of the conjunctiva in the medical literature, this type of nevus--a combination of a nevocytic and a blue nevus--is common and has been overlooked in the past.  (+info)

Evaluation of ocular tumors with technetium-99m-MIBI: planar pinhole technique or SPECT? (8/169)

OBJECTIVE: This study compares 2 imaging protocols, planar pinhole technique (PPHT) and SPECT, for evaluating ocular masses with 99mTc-MIBI. METHODS: Sixteen patients with ocular lesions were studied. Planar images were acquired 10 min after the injection of 740 MBq 99mTc-MIBI with an LFOV camera fitted with a pinhole collimator (5.0 mm). A SPECT study was performed immediately after the planar study, using a 360 degrees orbit, 64 steps, 20 s/stop, a 128 x 128 matrix, and a low-energy high-resolution (LEHR) collimator. Twelve lesions (9.5-18.0 mm) proved to be malignant: 8 primary tumors (ocular melanoma); 3 local relapses of different tumors of the conjunctiva; and 1 ocular metastasis from breast cancer. The remaining 4 lesions (10.0-16.0 mm) were benign: 1 inflammatory lesion; 1 benign intraocular calcification; and 2 naevi. RESULTS: SPECT images showed 11 of 12 malignant lesions (91.6%), whereas the planar technique demonstrated only 4 of the 12 lesions (33.3%). One false-positive result, the inflammatory lesion, was visualized by both techniques. The remaining benign lesions were not detected with either method. CONCLUSION: Technetium-99m-MIBI SPECT is a sensitive technique for detecting malignant ocular tumors. SPECT imaging is a better alternative to planar imaging for ocular tumors.  (+info)

Benign conjunctival neoplasms include:

* Conjunctival papillomas: These are small, finger-like growths that are usually benign but can sometimes become inflamed or infected.
* Pinguecula: These are small, yellowish patches that can develop on the conjunctiva and are usually benign but can occasionally become malignant.
* Conjunctival granulomas: These are small, raised bumps that form in response to inflammation or infection and are usually benign.

Malignant conjunctival neoplasms include:

* Squamous cell carcinoma: This is the most common type of malignant conjunctival tumor and is often caused by exposure to UV radiation. It can be treated with surgery, radiation therapy, or chemotherapy.
* Adenocarcinoma: This type of cancer develops in the glands that line the conjunctiva and is less common than squamous cell carcinoma. It can be treated with surgery, radiation therapy, or chemotherapy.
* Melanoma: This is a rare and aggressive form of eye cancer that can occur on the conjunctiva. It is often caused by exposure to UV radiation and can be difficult to treat.

Symptoms of conjunctival neoplasms can include:

* A mass or lesion on the conjunctiva
* Redness, swelling, or discharge in the eye
* Blurred vision or sensitivity to light
* Pain or discomfort in the eye

Diagnosis of conjunctival neoplasms is typically made through a combination of physical examination, imaging tests (such as ultrasound or MRI), and biopsy. Treatment options vary depending on the type and severity of the neoplasm, but may include surgery, radiation therapy, or chemotherapy.

Prognosis for conjunctival neoplasms depends on the type and stage of the disease at the time of diagnosis. In general, early detection and treatment improve the chances of a good outcome. However, some types of conjunctival neoplasms can be more aggressive and difficult to treat, and may have a lower prognosis.

Prevention of conjunctival neoplasms includes avoiding exposure to UV radiation by wearing protective eyewear (such as sunglasses or hats with UV protection) and seeking regular eye exams to detect any abnormalities early on.

Pancreatic adenocarcinoma is the most common type of malignant pancreatic neoplasm and accounts for approximately 85% of all pancreatic cancers. It originates in the glandular tissue of the pancreas and has a poor prognosis, with a five-year survival rate of less than 10%.

Pancreatic neuroendocrine tumors (PNETs) are less common but more treatable than pancreatic adenocarcinoma. These tumors originate in the hormone-producing cells of the pancreas and can produce excess hormones that cause a variety of symptoms, such as diabetes or high blood sugar. PNETs are classified into two main types: functional and non-functional. Functional PNETs produce excess hormones and are more aggressive than non-functional tumors.

Other rare types of pancreatic neoplasms include acinar cell carcinoma, ampullary cancer, and oncocytic pancreatic neuroendocrine tumors. These tumors are less common than pancreatic adenocarcinoma and PNETs but can be equally aggressive and difficult to treat.

The symptoms of pancreatic neoplasms vary depending on the type and location of the tumor, but they often include abdominal pain, weight loss, jaundice, and fatigue. Diagnosis is typically made through a combination of imaging tests such as CT scans, endoscopic ultrasound, and biopsy. Treatment options for pancreatic neoplasms depend on the type and stage of the tumor but may include surgery, chemotherapy, radiation therapy, or a combination of these.

Prognosis for patients with pancreatic neoplasms is generally poor, especially for those with advanced stages of disease. However, early detection and treatment can improve survival rates. Research into the causes and mechanisms of pancreatic neoplasms is ongoing, with a focus on developing new and more effective treatments for these devastating diseases.




Neoplasm refers to an abnormal growth of cells that can be benign (non-cancerous) or malignant (cancerous). Neoplasms can occur in any part of the body and can affect various organs and tissues. The term "neoplasm" is often used interchangeably with "tumor," but while all tumors are neoplasms, not all neoplasms are tumors.

Types of Neoplasms

There are many different types of neoplasms, including:

1. Carcinomas: These are malignant tumors that arise in the epithelial cells lining organs and glands. Examples include breast cancer, lung cancer, and colon cancer.
2. Sarcomas: These are malignant tumors that arise in connective tissue, such as bone, cartilage, and fat. Examples include osteosarcoma (bone cancer) and soft tissue sarcoma.
3. Lymphomas: These are cancers of the immune system, specifically affecting the lymph nodes and other lymphoid tissues. Examples include Hodgkin lymphoma and non-Hodgkin lymphoma.
4. Leukemias: These are cancers of the blood and bone marrow that affect the white blood cells. Examples include acute myeloid leukemia (AML) and chronic lymphocytic leukemia (CLL).
5. Melanomas: These are malignant tumors that arise in the pigment-producing cells called melanocytes. Examples include skin melanoma and eye melanoma.

Causes and Risk Factors of Neoplasms

The exact causes of neoplasms are not fully understood, but there are several known risk factors that can increase the likelihood of developing a neoplasm. These include:

1. Genetic predisposition: Some people may be born with genetic mutations that increase their risk of developing certain types of neoplasms.
2. Environmental factors: Exposure to certain environmental toxins, such as radiation and certain chemicals, can increase the risk of developing a neoplasm.
3. Infection: Some neoplasms are caused by viruses or bacteria. For example, human papillomavirus (HPV) is a common cause of cervical cancer.
4. Lifestyle factors: Factors such as smoking, excessive alcohol consumption, and a poor diet can increase the risk of developing certain types of neoplasms.
5. Family history: A person's risk of developing a neoplasm may be higher if they have a family history of the condition.

Signs and Symptoms of Neoplasms

The signs and symptoms of neoplasms can vary depending on the type of cancer and where it is located in the body. Some common signs and symptoms include:

1. Unusual lumps or swelling
2. Pain
3. Fatigue
4. Weight loss
5. Change in bowel or bladder habits
6. Unexplained bleeding
7. Coughing up blood
8. Hoarseness or a persistent cough
9. Changes in appetite or digestion
10. Skin changes, such as a new mole or a change in the size or color of an existing mole.

Diagnosis and Treatment of Neoplasms

The diagnosis of a neoplasm usually involves a combination of physical examination, imaging tests (such as X-rays, CT scans, or MRI scans), and biopsy. A biopsy involves removing a small sample of tissue from the suspected tumor and examining it under a microscope for cancer cells.

The treatment of neoplasms depends on the type, size, location, and stage of the cancer, as well as the patient's overall health. Some common treatments include:

1. Surgery: Removing the tumor and surrounding tissue can be an effective way to treat many types of cancer.
2. Chemotherapy: Using drugs to kill cancer cells can be effective for some types of cancer, especially if the cancer has spread to other parts of the body.
3. Radiation therapy: Using high-energy radiation to kill cancer cells can be effective for some types of cancer, especially if the cancer is located in a specific area of the body.
4. Immunotherapy: Boosting the body's immune system to fight cancer can be an effective treatment for some types of cancer.
5. Targeted therapy: Using drugs or other substances to target specific molecules on cancer cells can be an effective treatment for some types of cancer.

Prevention of Neoplasms

While it is not always possible to prevent neoplasms, there are several steps that can reduce the risk of developing cancer. These include:

1. Avoiding exposure to known carcinogens (such as tobacco smoke and radiation)
2. Maintaining a healthy diet and lifestyle
3. Getting regular exercise
4. Not smoking or using tobacco products
5. Limiting alcohol consumption
6. Getting vaccinated against certain viruses that are associated with cancer (such as human papillomavirus, or HPV)
7. Participating in screening programs for early detection of cancer (such as mammograms for breast cancer and colonoscopies for colon cancer)
8. Avoiding excessive exposure to sunlight and using protective measures such as sunscreen and hats to prevent skin cancer.

It's important to note that not all cancers can be prevented, and some may be caused by factors that are not yet understood or cannot be controlled. However, by taking these steps, individuals can reduce their risk of developing cancer and improve their overall health and well-being.

Cystic neoplasms are fluid-filled sacs that grow in the body. They can be benign or malignant and can arise from a variety of tissues, including the ovaries, pancreas, and lungs. Mucinous neoplasms are tumors that produce mucin, a type of protein found in mucus. These tumors can occur in the breast, ovary, or colon, and are often benign.

Serous neoplasms are tumors that arise from the serous membranes, which are the thin layers of tissue that line the cavities of the body. Examples of serous neoplasms include ovarian cancer and mesothelioma. These tumors can be benign or malignant.

In summary, neoplasms, cystic, mucinous, and serous are different types of tumors that can occur in various organs and tissues throughout the body. While they can be benign, many of these tumors are malignant and can spread to other parts of the body if left untreated.

There are several types of skin neoplasms, including:

1. Basal cell carcinoma (BCC): This is the most common type of skin cancer, and it usually appears as a small, fleshy bump or a flat, scaly patch. BCC is highly treatable, but if left untreated, it can grow and invade surrounding tissue.
2. Squamous cell carcinoma (SCC): This type of skin cancer is less common than BCC but more aggressive. It typically appears as a firm, flat, or raised bump on sun-exposed areas. SCC can spread to other parts of the body if left untreated.
3. Melanoma: This is the most serious type of skin cancer, accounting for only 1% of all skin neoplasms but responsible for the majority of skin cancer deaths. Melanoma can appear as a new or changing mole, and it's essential to recognize the ABCDE signs (Asymmetry, Border irregularity, Color variation, Diameter >6mm, Evolving size, shape, or color) to detect it early.
4. Sebaceous gland carcinoma: This rare type of skin cancer originates in the oil-producing glands of the skin and can appear as a firm, painless nodule on the forehead, nose, or other oily areas.
5. Merkel cell carcinoma: This is a rare and aggressive skin cancer that typically appears as a firm, shiny bump on the skin. It's more common in older adults and those with a history of sun exposure.
6. Cutaneous lymphoma: This type of cancer affects the immune system and can appear as a rash, nodules, or tumors on the skin.
7. Kaposi sarcoma: This is a rare type of skin cancer that affects people with weakened immune systems, such as those with HIV/AIDS. It typically appears as a flat, red or purple lesion on the skin.

While skin cancers are generally curable when detected early, it's important to be aware of your skin and notice any changes or unusual spots, especially if you have a history of sun exposure or other risk factors. If you suspect anything suspicious, see a dermatologist for an evaluation and potential biopsy. Remember, prevention is key to avoiding the harmful effects of UV radiation and reducing your risk of developing skin cancer.

Multiple primary neoplasms can arise in different organs or tissues throughout the body, such as the breast, colon, prostate, lung, or skin. Each tumor is considered a separate entity, with its own unique characteristics, including size, location, and aggressiveness. Treatment for multiple primary neoplasms typically involves surgery, chemotherapy, radiation therapy, or a combination of these modalities.

The diagnosis of multiple primary neoplasms can be challenging due to the overlapping symptoms and radiological findings between the different tumors. Therefore, it is essential to have a thorough clinical evaluation and diagnostic workup to rule out other possible causes of the symptoms and confirm the presence of multiple primary neoplasms.

Multiple primary neoplasms are more common than previously thought, with an estimated prevalence of 2% to 5% in some populations. The prognosis for patients with multiple primary neoplasms varies depending on the location, size, and aggressiveness of each tumor, as well as the patient's overall health status.

It is important to note that multiple primary neoplasms are not the same as metastatic cancer, in which a single primary tumor spreads to other parts of the body. Multiple primary neoplasms are distinct tumors that arise independently from different primary sites within the body.

Symptoms of Kidney Neoplasms can include blood in the urine, pain in the flank or abdomen, weight loss, fever, and fatigue. Diagnosis is made through a combination of physical examination, imaging studies such as CT scans or ultrasound, and tissue biopsy. Treatment options vary depending on the type and stage of the neoplasm, but may include surgery, ablation therapy, targeted therapy, or chemotherapy.

It is important for individuals with a history of Kidney Neoplasms to follow up with their healthcare provider regularly for monitoring and check-ups to ensure early detection of any recurrences or new tumors.

Previous articleNeoplastic Cells
Next articleNephrocalcinosis

Examples of 'Adenocarcinoma, Mucinous' in medical literature:

* The patient was diagnosed with adenocarcinoma, mucinous type, in their colon after undergoing a colonoscopy and biopsy. (From the Journal of Clinical Oncology)

* The patient had a history of adenocarcinoma, mucinous type, in their breast and was being monitored for potential recurrence. (From the Journal of Surgical Oncology)

* The tumor was found to be an adenocarcinoma, mucinous type, with a high grade and was treated with surgery and chemotherapy. (From the Journal of Gastrointestinal Oncology)

Synonyms for 'Adenocarcinoma, Mucinous' include:

* Mucinous adenocarcinoma
* Colon adenocarcinoma, mucinous type
* Rectal adenocarcinoma, mucinous type
* Adenocarcinoma of the colon and rectum, mucinous type.

There are several types of thyroid neoplasms, including:

1. Thyroid nodules: These are abnormal growths or lumps that can develop in the thyroid gland. Most thyroid nodules are benign (non-cancerous), but some can be malignant (cancerous).
2. Thyroid cancer: This is a type of cancer that develops in the thyroid gland. There are several types of thyroid cancer, including papillary, follicular, and medullary thyroid cancer.
3. Thyroid adenomas: These are benign tumors that develop in the thyroid gland. They are usually non-cancerous and do not spread to other parts of the body.
4. Thyroid cysts: These are fluid-filled sacs that can develop in the thyroid gland. They are usually benign and do not cause any symptoms.

Thyroid neoplasms can be caused by a variety of factors, including genetic mutations, exposure to radiation, and certain medical conditions, such as thyroiditis (inflammation of the thyroid gland).

Symptoms of thyroid neoplasms can include:

* A lump or swelling in the neck
* Pain in the neck or throat
* Difficulty swallowing or breathing
* Hoarseness or voice changes
* Weight loss or fatigue

Diagnosis of thyroid neoplasms usually involves a combination of physical examination, imaging tests (such as ultrasound or CT scans), and biopsies. Treatment depends on the type and severity of the neoplasm, and can include surgery, radiation therapy, and medications.

There are several types of MPDs, including:

1. Polycythemia vera (PV): This is a rare disorder characterized by an overproduction of red blood cells, white blood cells, and platelets.
2. Essential thrombocythemia (ET): This is a rare disorder characterized by an overproduction of platelets.
3. Primary myelofibrosis (PMF): This is a rare and severe disorder characterized by the accumulation of scar tissue in the bone marrow, leading to an overproduction of immature white blood cells.
4. Chronic myelogenous leukemia (CML): This is a type of cancer that affects the bone marrow and blood cells, characterized by the overproduction of immature white blood cells.

The symptoms of MPDs can vary depending on the specific disorder, but may include:

* Fatigue
* Weakness
* Shortness of breath
* Headaches
* Dizziness
* Pale skin
* Easy bruising or bleeding
* Swollen spleen
* Bone pain

The exact cause of MPDs is not known, but they are thought to be due to genetic mutations that occur in the bone marrow cells. Treatment options for MPDs include:

* Chemotherapy: This is a type of drug that kills cancer cells.
* Radiation therapy: This is a type of treatment that uses high-energy X-rays to kill cancer cells.
* Stem cell transplantation: This is a procedure in which healthy stem cells are transplanted into the body to replace damaged or diseased bone marrow cells.

Overall, MPDs are rare and complex disorders that can have a significant impact on quality of life. While there is no cure for these conditions, treatment options are available to help manage symptoms and improve outcomes.

"Conjunctival Kaposi's Sarcoma - The Eye Cancer Network". Archived from the original on 2010-11-24. Retrieved 2010-03-10. " ... Eye neoplasms can affect all parts of the eye, and can be a benign tumor or a malignant tumor (cancer). Eye cancers can be ... "Pigmented Conjunctival Tumors - The Eye Cancer Network". Archived from the original on 2009-08-20. Retrieved 2010-03-10. " ... "General Information: Malignant Conjunctival Tumors - The Eye Cancer Network". Archived from the original on 2010-11-24. ...
Squamous cell carcinoma of eye tissues is one of the most frequent neoplasms of cattle. On third eyelid, papilloma-like (see ... Conjunctival squamous cell carcinoma (conjunctival SCC) and corneal intraepithelial neoplasia comprise what are called ocular ... Treatment of conjunctival SCC is usually surgical excision followed by cryotherapy. After this procedure, Conjunctival SCC can ... Mortality for conjunctival SCC ranges from 0-8%. Diagnosis is often made by biopsy, as well as CT (in the case of invasive SCC ...
The corneal limbus is a common site for the occurrence of corneal epithelial neoplasm. Aniridia, a developmental anomaly of the ... and differential diagnosis of conjunctival and corneal tumors", Clinical Ophthalmic Oncology, Edinburgh: W.B. Saunders, pp. 125 ... iris, disrupts the normal barrier of the cornea to the conjunctival epithelial cells at the limbus. The corneal limbus may be ...
... conjunctival neoplasms MeSH C11.319.421 - eyelid neoplasms MeSH C11.319.457 - orbital neoplasms MeSH C11.319.475 - retinal ... iris neoplasms MeSH C11.941.375.385 - iritis MeSH C11.941.855 - uveal neoplasms MeSH C11.941.855.198 - choroid neoplasms MeSH ... uveal neoplasms MeSH C11.319.494.198 - choroid neoplasms MeSH C11.319.494.400 - iris neoplasms MeSH C11.338.133 - blepharitis ... MeSH C11.187.169 - conjunctival neoplasms MeSH C11.187.183 - conjunctivitis MeSH C11.187.183.200 - conjunctivitis, allergic ...
Eye neoplasm Carol Lally Shields Archived 2008-07-06 at the Wayback Machine biography at the University of Notre Dame Athletics ... and Atlas of Eyelid and Conjunctival Tumors. She is also co- editor of a comprehensive book entitled, "Retinoblastoma", ...
Benign neoplasms, Papillomavirus-associated diseases, All stub articles, Neoplasm stubs). ... Papilloma, Conjunctival at eMedicine National Library for Health (2007). "Squamous cell papilloma". National Library for Health ... Normally found in children or young adults, a common cause of conjunctival squamous cell papilloma is during childbirth, when ...
... conjunctival neoplasms MeSH C04.588.364.659 - orbital neoplasms MeSH C04.588.364.818 - retinal neoplasms MeSH C04.588.364.818. ... skull base neoplasms MeSH C04.588.149.828 - spinal neoplasms MeSH C04.588.180.260 - breast neoplasms, male MeSH C04.588.180.390 ... bile duct neoplasms MeSH C04.588.274.120.250.250 - common bile duct neoplasms MeSH C04.588.274.120.401 - gallbladder neoplasms ... femoral neoplasms MeSH C04.588.149.721 - skull neoplasms MeSH C04.588.149.721.450 - jaw neoplasms MeSH C04.588.149.721.450.583 ...
Neoplasm should be considered in any patient presenting with nasolacrimal duct obstruction. In patients with atypical ... the examiner instills fluorescein into the conjunctival fornices of each eye and then observes the tear film, preferably with ... Bloody punctual discharge or lacrimal sac distension above the medial canthal tendon is also highly suggestive of neoplasm. ...
... attributed to intracranial neoplasm Headache attributed to increased intracranial pressure or hydrocephalus caused by neoplasm ... tension-type headache Cluster headache Paroxysmal hemicrania Short-lasting unilateral neuralgiform headache with conjunctival ... Headache attributed directly to neoplasm Headache attributed to carcinomatous meningitis Headache attributed to hypothalamic or ...
... s represent from 10% to 25% of all intracranial neoplasms and the estimated prevalence rate in the general ... short-lasting unilateral neuralgiform headache attacks with conjunctival injection and tearing (SUNCT) - another type of ...
Stewart SE, Eddy BE, Borgese N (June 1958). "Neoplasms in mice inoculated with a tumor agent carried in tissue culture". ... October 2007). "Human transcriptome subtraction by using short sequence tags to search for tumor viruses in conjunctival ... Rous P (September 1910). "A Transmissible Avian Neoplasm. (Sarcoma of the Common Fowl.)". The Journal of Experimental Medicine ...
List of human cell types derived from the germ layers Hodges, R.R.; Dartt, D.A. (2010). "Conjunctival Goblet Cells". ... McCusker, ME; Coté, TR; Clegg, LX; Sobin, LH (2002). "Primary malignant neoplasms of the appendix: a population-based study ...
Patients present with conjunctival (25% of cases) or intra-orbital (75% of cases) lesions which typically involve one eye but ... "The 2016 revision of the World Health Organization classification of lymphoid neoplasms". Blood. 127 (20): 2375-90. doi:10.1182 ... Tanenbaum RE, Galor A, Dubovy SR, Karp CL (2019). "Classification, diagnosis, and management of conjunctival lymphoma". Eye and ... in 10-15% of cases, particularly in conjunctival cases, involve both eyes. Conjunctiva lesions usually present as a salmon red ...
Gear H, Williams H, Kemp EG, Roberts F (August 2004). "BRAF mutations in conjunctival melanoma". Investigative Ophthalmology & ... a benign but locally infiltrative odontogenic neoplasm. The V600E mutation may also be linked, as a single-driver mutation (a ...
Conjunctival Neoplasms* / drug therapy Actions. * Search in PubMed * Search in MeSH * Add to Search ... Ateenyi-Agaba C. Conjunctival squamous-cell carcinoma associated with HIV infection in Kampala, Uganda. The Lancet. 1995;345( ... Survival analysis of conjunctival intraepithelial neoplasia treated with topical chemotherapy. The median survival was 10 weeks ... Conjunctival/Corneal intraepithelial neoplasia. Int Ophthalmol Clin. 2009;49(1):63-70. doi: 10.1097/IIO.0b013e3181924ec3. - DOI ...
Conjunctival neoplasms/surgery; Melanoma; Disease-free survival; Survival analysis. Objetivo:. Descrever o intervalo livre de ... In the past, conjunctival melanoma implied an orbital exenteration(1313. Fang ZJ, He WM. A fast growing conjunctival malignant ... Pigmented conjunctival growing lesion in a teenager: nevus or melanoma? Can J Ophthalmol. 2013;48(6): e154-6.). Conjunctival ... A fast growing conjunctival malignant melanoma. Chin Med J. 2013;126(18):3593.). Surgical treatment of conjunctival melanoma ...
Conjunctival Neoplasms -- WW 212. *Cord Blood Stem Cell Transplantation -- WH 140. *Cosmeceuticals -- QV 60 ... QZ 200-380 Neoplasms. Cysts was changed to QZ 200-380 Neoplasms ... QZ 310-380 Specific Types of Neoplasms was added. Revisions to ... on experimental work on the etiology of neoplasms in QZ 202" to "Classify here all works on experimental neoplasms regardless ... "Classify here popular works on neoplasms in general. Classify popular works on neoplasms by site in the appropriate schedule." ...
16] Sebaceous neoplasms developed before or concurrent with visceral malignancies in 41% of patients in one series. [16] ... Conjunctival map biopsy to determine pagetoid spread. Am J Ophthalmol. 1986 Jul 15. 102(1):87-90. [QxMD MEDLINE Link]. ... 14] A diagnosis of Muir-Torre syndrome requires the presence of both an internal malignancy and a sebaceous neoplasm. [14] The ... Conjunctival epithelial involvement by eyelid sebaceous carcinoma. The 2003 J. Howard Stokes lecture. Ophthal Plast Reconstr ...
Conjunctival Melanoma in Childhood and Adolescence: A Systematic Review Ocul Oncol Pathol (April,2019) ... FNAC is certainly a valid and accurate diagnostic tool for this type of neoplasm, even in the paediatric age, allowing the ... Patients affected by a previous solid or leukaemic neoplasm during their childhood may develop a second different tumour during ... In this setting, salivary gland MEC is relatively frequent, accounting for 6% of the second neoplasms in paediatric patients. ...
6. Pigmented conjunctival neoplasms.. Rodriguez-Sains RS. Orbit; 2002 Sep; 21(3):231-8. PubMed ID: 12187419. [TBL] ... 2. Pigmented conjunctival and scleral lesions.. Liesegang TJ. Mayo Clin Proc; 1994 Feb; 69(2):151-61. PubMed ID: 8309267. [TBL] ... 4. Conjunctival pigmented lesion: Clinicopathological analysis of 85 cases in Korean population.. Lee YJ; Lee C; Kim MK; Khwarg ... 5. Conjunctival melanosis and melanoma.. Folberg R; McLean IW; Zimmerman LE. Ophthalmology; 1984 Jun; 91(6):673-8. PubMed ID: ...
Categories: Conjunctival Neoplasms Image Types: Photo, Illustrations, Video, Color, Black&White, PublicDomain, ...
Conjunctival Neoplasms / etiology Actions. * Search in PubMed * Search in MeSH * Add to Search ... Dry and atrophic skin with scaly hyperpigmented macules in a child with conjunctival injection and excessive corneal ...
Corneal and conjunctival disorders have occurred with topical fluorouracil use [see Adverse Reactions (6.2)]. Avoid application ... Neoplasms: chronic lymphocytic leukemia, non-melanoma skin cancer Nervous system disorders: insomnia, irritability ... Eye disorders: corneal disorder, conjunctival disorder, eye irritation, conjunctivitis, lacrimation. Gastrointestinal disorders ...
Conjunctival map biopsy to determine pagetoid spread. Am J Ophthalmol. 1986 Jul 15. 102(1):87-90. [QxMD MEDLINE Link]. ... However, their sensitivity in sebaceous carcinoma has been reported to be less than that of other sebaceous neoplasms. [74, 75 ... Conjunctival map biopsies are recommended to delineate the presence and extent of pagetoid spread. [83] ... A scoring system developed by Roberts et al may be useful in identifying patients with sebaceous neoplasms at risk for Muir- ...
Neoplasms [C04] * Neoplasms by Site [C04.588] * Eye Neoplasms [C04.588.364] * Conjunctival Neoplasms [C04.588.364.235] ... Conjunctival Neoplasms Preferred Concept UI. M0005014. Scope Note. Tumors or cancer of the CONJUNCTIVA.. Terms. Conjunctival ... Conjunctival Neoplasms. Tree Number(s). C04.588.364.235. C11.187.169. C11.319.217. Unique ID. D003230. RDF Unique Identifier. ... CONJUNCTIVAL NEOPL. NLM Classification #. WW 212. Previous Indexing. Conjunctiva (1966-1980). Eye Neoplasms (1966-1980). Public ...
Neoplasms [C04] * Neoplasms by Site [C04.588] * Eye Neoplasms [C04.588.364] * Conjunctival Neoplasms [C04.588.364.235] ... Conjunctival Neoplasms Preferred Concept UI. M0005014. Scope Note. Tumors or cancer of the CONJUNCTIVA.. Terms. Conjunctival ... Conjunctival Neoplasms. Tree Number(s). C04.588.364.235. C11.187.169. C11.319.217. Unique ID. D003230. RDF Unique Identifier. ... CONJUNCTIVAL NEOPL. NLM Classification #. WW 212. Previous Indexing. Conjunctiva (1966-1980). Eye Neoplasms (1966-1980). Public ...
Conjunctival Neoplasms; Retrospective Studies; Female; Male; Male; Female; Humans; Conjunctival Neoplasms; Retrospective ... It is used more frequently to cover conjunctival and corneal defects. In our retrospective study we have been combined 68 ... Amniotic membrane application in surgical treatment of conjunctival tumors.pdf - Published Version Available under License ... Amniotic membrane application in surgical treatment of conjunctival tumors. Scientific Reports, 13 (1). ISSN 2045-2322 ...
Management of Primary Acquired Melanosis, Nevus, and Conjunctival Melanoma. Cancer Control. 2016 Apr; 23(2):117-25. Kao A, ... Neo Neoplasms. Translation:Humans * Practice Considerations for Proton Beam Radiation Therapy of Uveal Melanoma During the ...
... and some neoplasms such as Hodgkins lymphoma. Because of this, patients with atypical granuloma or elderly patients should be ... and other mucosal and conjunctival tissues. The reticular form with whitish intertwined lesions forming a network symmetrically ... and neoplasms. Several pro-inflammatory cytokines such as interleukin-2, 4, 6 and 10, tumor necrosis factor-alpha, interferon ...
Dive into the research topics of Congenital smooth muscle hamartoma of the conjunctival fornix. Together they form a unique ...
Neoplasms [C04] * Neoplasms by Site [C04.588] * Eye Neoplasms [C04.588.364] * Conjunctival Neoplasms [C04.588.364.235] ... Conjunctival Neoplasms Preferred Concept UI. M0005014. Scope Note. Tumors or cancer of the CONJUNCTIVA.. Terms. Conjunctival ... Conjunctival Neoplasms. Tree Number(s). C04.588.364.235. C11.187.169. C11.319.217. Unique ID. D003230. RDF Unique Identifier. ... CONJUNCTIVAL NEOPL. NLM Classification #. WW 212. Previous Indexing. Conjunctiva (1966-1980). Eye Neoplasms (1966-1980). Public ...
Undetermined C2907 Brain Neoplasm Brain Neoplasms ,, Brain Tumor ,, Neoplasm of Brain ,, Neoplasm of the Brain ,, Tumor of ... Benign C4549 Conjunctival Squamous Cell Carcinoma Conjunctiva Epidermoid Carcinoma ,, Conjunctiva Squamous Cell Carcinoma ,, ... Rhabdoid Neoplasm of CNS ,, Rhabdoid Neoplasm of Central Nervous System ,, Rhabdoid Neoplasm of the CNS ,, Rhabdoid Neoplasm of ... Benign C6449 Benign Germ Cell Tumor Benign Germ Cell Neoplasm ,, Benign Neoplasm of Germ Cell ,, Benign Neoplasm of the Germ ...
The prevalence of participants with conjunctival nevi, iris nevi, and chordal nevi amounted to 0.9 and and nonindustrial ... Follow-up Examinations for Occular Neoplasms and Pigmented Ocular Lesions, at the Dupont, West Virginia Plant. ... were ophthalmologically surveyed first in 1978 and again in 1979 in a follow-up study to identify cases of ocular neoplasms and ...
Its differential diagnosis with other conjunctival melanocytic neoplasms is inherently difficult. The presence of epithelial ... Conjunctival melanoma is the second most common conjunctival malignancy. ... Herein 2 cases of conjunctival melanoma with cysts are presented. To the best of our knowledge, this is the first series of ... Epithelial Inclusion Cyst in Conjunctival Melanoma. Esposito, Evangelina; Zoroquiain, Pablo; Mastromonaco, Christina; Morales, ...
Conjunctival Neoplasms 1 0 Melanoma 1 0 Neoplasm Metastasis 1 0 Note: The number of publications displayed in this table will ...
Conjunctival Neoplasm. Neoplasm, Conjunctival. Neoplasms, Conjunctival. Tree number(s):. C04.588.364.235. C11.187.169. C11.319. ... coordinate with histological type of neoplasm. Allowable Qualifiers:. BL blood. BS blood supply. CF cerebrospinal fluid. CH ...
Choroid Neoplasms, Brachytherapy, Eye Enucleation, Iris Neoplasms, Ciliary Body, Conjunctiva, Conjunctival Neoplasms, Anatomy, ... Head and Neck Neoplasms, Breast Neoplasms, Nevi and Melanomas, Skin Neoplasms, Central Nervous System Neoplasms, ... Neoplasms, Head and Neck Neoplasms, Mouth Neoplasms, Surgical Procedures, Operative, General Surgery, Salivary Gland Neoplasms ... Breast Neoplasms, Prostatic Neoplasms, Lung Neoplasms, Colonic Neoplasms, Social Conditions, 50334, Carcinoma, Non-Small-Cell ...
Conjunctival Neoplasms. Retinoblastoma. Retinitis 4. An ophthalmoscopic study of a case of hemorrhagic neuro-retinitis ...
Conjunctival squamous cell carcinoma 133. Conjunctival vascular neoplasia 133. Miscellaneous neoplasms of the third eyelid 133 ... Secondary intraocular neoplastic extension from primary nasal and orbital and adnexal neoplasms 435 ...
  • Ocular surface squamous neoplasia (OSSN) comprises a wide spectrum of squamous tumors, from which corneal/conjunctival intraepithelial neoplasia (CIN) is the most common one. (nih.gov)
  • 25. Expression of p63 in conjunctival intraepithelial neoplasia and squamous cell carcinoma. (nih.gov)
  • Compared to conjunctival intraepithelial neoplasia (CIN), the term OSSN may be more favorable clinically due to our inability to assess the lesion's depth and define it by its extension without an invasive biopsy. (reviewofcontactlenses.com)
  • The results of our study indicate that AM grafts are an effective alternative to cover defects after removal of epibulbar lesions due to their anti-inflammatory properties because the conjunctiva must be preserved, and especially the most important application is in malignant epibulbar conjunctival tumors. (ljmu.ac.uk)
  • To describe the cases of conjunctival melanoma (CM) and report the disease-free interval (DFI) and overall survival (OS). (scielo.br)
  • Conjunctival melanoma is a rare entity. (scielo.br)
  • Conjunctival melanoma and primary acquired melanosis (PAM) are pigmented lesions of the ocular surface. (scielo.br)
  • The incidence of conjunctival melanoma is low, estimated to occur in 0.2 to 0.5 cases/million of the Caucasian population. (scielo.br)
  • We have identified 2 groups of patients: (a) 2 cases with previous history of malignancy (acute lymphoblastic leukaemia and Hodgkin lymphoma) and (b) 3 cases without previous malignant neoplasms. (karger.com)
  • [ 26 ] Controversy exists regarding the prophylactic removal of a nevus sebaceous, but when malignant neoplasms are suspected, removal is warranted regardless. (medscape.com)
  • 22. Human papillomavirus in normal conjunctival tissue and in conjunctival papilloma: types and frequencies in a large series. (nih.gov)
  • Individual epithelial cells or sheets of cells with brown-black pigmented cytoplasmic granules is characteristic of normal conjunctival cytology. (dvm360.com)
  • 34. Topical mitomycin C for extensive, recurrent conjunctival-corneal squamous cell carcinoma. (nih.gov)
  • It is used more frequently to cover conjunctival and corneal defects. (ljmu.ac.uk)
  • When evaluating any conjunctival or corneal lesion, our list of potential diagnoses should remain broad initially. (reviewofcontactlenses.com)
  • In our retrospective study we have been combined 68 patients with epibulbar conjunctival tumors they have been surgically treated in the period of 2011-2021. (ljmu.ac.uk)
  • 23. Expression, intracellular localization, and mutation of EGFR in conjunctival squamous cell carcinoma and the association with prognosis and treatment. (nih.gov)
  • 32. Expression of αB-crystallin and vascular endothelial growth factor in conjunctival squamous cell carcinoma. (nih.gov)
  • 37. Prevalence of HIV with conjunctival squamous cell neoplasia in an African provincial hospital. (nih.gov)
  • [ 19 ] In these rare cases, the sebaceous gland carcinoma may fill the conjunctival epithelium and create the appearance of squamous cell carcinoma in situ. (medscape.com)
  • Code Preferred Term Synonyms Definition Neoplastic Status C7419 Acanthoma A benign skin neoplasm composed of epithelial cells. (nih.gov)
  • The dye uptake is not specific to neoplasms, however, and may be seen in some benign lesions or severe dry eye syndrome. (reviewofcontactlenses.com)
  • [ 2 ] In contrast, most acquired melanocytic nevi are considered benign neoplasms. (medscape.com)
  • Each dye will stain devitalized or degenerated epithelial cells, which are commonly seen in epithelial neoplasms. (reviewofcontactlenses.com)
  • INTRODUCCIÓN: En Argentina, la Sociedad Argentina de Oftalmología Infantil recomienda el examen ocular por parte de un especialista para todos los niños cuando nacen, a los seis meses, a los tres años y al inicio de la etapa escolar. (bvsalud.org)
  • Follow-up Examinations for Occular Neoplasms and Pigmented Ocular Lesions, at the Dupont, West Virginia Plant. (cdc.gov)
  • Active and retired workers at the duPont Belle chemicals facility in West Virginia were ophthalmologically surveyed first in 1978 and again in 1979 in a follow-up study to identify cases of ocular neoplasms and determine the prevalence of ocular pigmented lesions. (cdc.gov)
  • In recent years, UHR-OCT has garnered attention as a noninvasive, in vivo imaging technique for ocular surface neoplasms. (reviewofcontactlenses.com)
  • A scoring system developed by Roberts et al may be useful in identifying patients with sebaceous neoplasms at risk for Muir-Torre syndrome, weighing in age at diagnosis, number of sebaceous neoplasms, and personal or family history of Lynch syndrome-related cancer. (medscape.com)
  • However, their sensitivity in sebaceous carcinoma has been reported to be less than that of other sebaceous neoplasms. (medscape.com)
  • Hepatoblastomas with carcinoma features represent a biological spectrum of aggressive hepatocellular neoplasms in children and adolescents. (bcm.edu)
  • Acinic Cell Carcinoma A malignant glandular epithelial neoplasm consisting of secretory cells forming acinar patterns. (nih.gov)
  • Orbital Neoplasms" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings) . (rush.edu)
  • The prevalence of participants with conjunctival nevi, iris nevi, and chordal nevi amounted to 0.9 and and nonindustrial workers, respectively. (cdc.gov)
  • Neoplasms of the bony orbit and contents except the eyeball. (rush.edu)
  • Single-cell transcriptional profiling of murine conjunctival immune cells reveals distinct populations expressing homeostatic and regulatory genes. (bcm.edu)
  • Below are the most recent publications written about "Orbital Neoplasms" by people in Profiles. (rush.edu)
  • Imaging helps determine lesion progression or therapeutic response in cases of suspected neoplasm. (reviewofcontactlenses.com)
  • Of the 22 patients, 72.72% had a history of conjunctival melanosis. (scielo.br)
  • Patients affected by a previous solid or leukaemic neoplasm during their childhood may develop a second different tumour during the follow-up. (karger.com)
  • In this setting, salivary gland MEC is relatively frequent, accounting for 6% of the second neoplasms in paediatric patients. (karger.com)
  • Consequently, the occurrence of salivary gland nodules in paediatric patients with a previous neoplasm should be considered an event with a high risk of malignancy that poses peculiar diagnostic challenges. (karger.com)
  • This study was designed to define clinical and instrumental findings and morphological features of MEC on fine-needle aspiration cytology (FNAC) samples in paediatric patients with and without a previous neoplasm. (karger.com)
  • Common conjunctival neoplasms. (nih.gov)
  • Classify popular works on neoplasms by site in the appropriate schedule. (nih.gov)
  • At QY 58, the note was changed from "Cf. QY 25 Laboratory manuals" to "Classify works on experimental neoplasms in QZ 206. (nih.gov)
  • At QZ 201, the note was changed from "Classify here popular works on all aspects of neoplasms" to "Classify here popular works on neoplasms in general. (nih.gov)
  • This graph shows the total number of publications written about "Orbital Neoplasms" by people in this website by year, and whether "Orbital Neoplasms" was a major or minor topic of these publications. (rush.edu)